 |
| Coleen Carter |
Colleen Carter, who was chief marketing officer at Fingerpaint Group healthcare communications shop, has joined JPA Health’s New York office as head of life sciences.
As Fingerpaint’s first CMO, Carter supported the evaluation and integration of 10 acquisitions, including companies in the medical education, managed care, multicultural, branding and promotion sectors. Fingerpaint has more than 800 staffers.
At JPA, she will oversee pharmaceutical, biotech, diagnostics, medical device, medtech and digital health clients, report to CEO Carrie Jones, and join the firm’s executive team.
Carter, who has more the 20 years of healthcare experience, learned from stints at Concentric Health Experience; JUICE Pharma; Harrison and Star; Kallir, Philips, Ross; CommonHealth and MedEd.
Jones said Carter “is a perfect fit for our agency and an invaluable asset as we continue expanding our capabilities globally.”
JPA ranks No. 12 in O'Dwyer's healthcare PR rankings with fee income of $24.3M in 2023.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
